Improving sensitivity of oral fluid testing in IgG prevalence studies: application of mixture models to a rubella antibody survey by Gay, N. J. et al.
  
University of Warwick institutional repository: http://go.warwick.ac.uk/wrap
This paper is made available online in accordance with 
publisher policies. Please scroll down to view the document 
itself. Please refer to the repository record for this item and our 
policy information available from the repository home page for 
further information.  
To see the final version of this paper please visit the publisher’s website. 
Access to the published version may require a subscription. 
 
Author(s): N. J. GAY, A. J. VYSE, F. ENQUSELASSIE, W. NIGATU and 
D. J. NOKES 
Article Title: Improving sensitivity of oral fluid testing in IgG prevalence 
studies: application of mixture models to a rubella antibody survey  
Year of publication: 2003 
Link to published 
version: http://dx.doi.org/10.1017/S0950268802008051 
Publisher statement: None 
 
 
 
Improving sensitivity of oral ﬂuid testing in IgG prevalence
studies: application of mixture models to a rubella
antibody survey
N. J. GAY 1*, A. J. VYSE1, F. ENQUSELASSIE2, W. NIGATU 3 AND D. J. NOKES 4#
1 Immunisation Division, PHLS Communicable Disease Surveillance Centre, 61 Colindale Avenue,
London NW9 5EQ, UK
2 Department of Community Health, Faculty of Medicine, University of Addis Ababa, Addis Ababa, Ethiopia
3 Department of Infectious and Other Disease Research, Ethiopian Health and Nutrition Research Institute,
Addis Ababa, Ethiopia
4 Department of Biological Sciences, University of Warwick, Coventry CV4 7AL, UK
(Accepted 19 October 2002)
SUMMARY
A method for the analysis of age-stratiﬁed antibody prevalence surveys is applied to a previously
reported survey of antibody to rubella virus using oral ﬂuid samples in which the sensitivity of the
assay used was shown to be compromised. The age-speciﬁc distribution of the quantitative results
of antibody tests using oral ﬂuids is modelled as a mixture of strong positive, weak positive and
negative components. This yields maximum likelihood estimates of the prevalence at each age and
demonstrates that, when used in conjunction with mixture modelling techniques, the results of
antibody prevalence studies using oral ﬂuids accurately reﬂect those obtained using sera.
INTRODUCTION
The aim of an age-stratiﬁed serological survey is to
determine the prevalence of antibody to a speciﬁc in-
fection in all age groups [1]. Of particular use in the
study of viral transmission and population immunity
is the measurement of long lasting IgG antibody in a
population. Traditionally serumhas been the specimen
of choice for such surveys, but blood collection is in-
vasive, hazardous, and relatively expensive, requiring
specially trained staﬀ to perform the procedure using
sterile equipment. A sample that is simple, safe and
cheap to collect is more desirable, especially for popu-
lation immunity studies where large numbers of speci-
mens need to be easily and economically obtained [2].
Oral ﬂuid is a feasible non-invasive alternative to serum
for this purpose as it is very simple, safe and cheap to
collect and contains immunoglobulins reﬂecting those
found in serum. Themajor drawback is that antibodies
are present at considerably lower concentrations in
oral ﬂuid and so require particularly sensitive assays.
In the context of viral-speciﬁc IgG, with the exception
of assays for human immunodeﬁciency virus type 1
(HIV-1) [3] , there is some concern that the technology
used in current protocols to detect speciﬁc antibody in
oral ﬂuid are not sensitive enough to enable oral ﬂuid
assays to replace serum assays [4–7].
Samples may be tested for the presence of antibody
using a variety of laboratory techniques, ELISA being
the most commonly used. Many assays also enable
results to be expressed numerically, assumed pro-
portional to the quantity of the speciﬁc antibody in the
sample. When assays are used on an individual basis,
perhaps for diagnostic purposes or pre-vaccination
screening, samples need to be categorized as positive
(containing speciﬁc antibody), negative (containing no
speciﬁc antibody) or equivocal (further tests necess-
ary). Cut-oﬀ values are set to deﬁne the boundaries
of these zones. Setting cut-oﬀ values is not straight-
forward unless there is clear separation of results into
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positive and negative peaks.When using oral ﬂuids it is
often diﬃcult to distinguish between negative samples
and those with low levels of speciﬁc antibody. How-
ever, when conducting a serological survey it may be
suﬃcient only to determine accurately the proportion
seropositive at each age – individual results are only of
interest for the contribution they make to the overall
picture (unless, for example, there is interest in identi-
fying predictors of serological status). In this setting,
an alternative approach is to derive the prevalence
from the age-speciﬁc distribution of results, rather
than using cut-oﬀs to categorize each sample [8].
Mixture models provide an appropriate method for
the analysis of the distribution of results, since the
samples are taken from a mixture of individuals who
have experienced infection and those who have not [8].
In this study we describe the application of mixture
models to a previously reported survey of rubella virus
antibody in a rural Ethiopian population using oral
ﬂuid samples [7]. Results from paired serum samples
were also available.Using a ﬁxed cut-oﬀ, the sensitivity
of the oral ﬂuid assay relative to the serum results was
shown to decrease with increasing age of subject, from
more than 90% in those aged less than 10 years to just
65% above age 40 years [7]. We investigated whether
analysing the results using an appropriate mixture
model would overcome this apparent lack of sensi-
tivity, enabling oral ﬂuid samples to be used success-
fully to investigate population immunity.
METHODS
Data
The serological data used here are taken from the re-
sults of a survey of IgG antibody to rubella virus in a
rural Ethiopian population [7] designed to determine
the potential of oral ﬂuid to replace serum for the
evaluation of population immunity levels. The data
comprise 837 optical density (OD) ratios (the OD
reading divided by that given by a reference serum
sample) obtained using an ‘ in house’ ampliﬁed IgG
antibody capture ELISA (GACELISA) [4] to screen
oral ﬂuid samples from persons aged 1–84 years. In-
dividual results were aggregated into six age groups
(1–4, 5–9, 10–14, 15–24, 25–44 and 45 years or more)
by 20 reactivity categories (equal width bands based on
the log(OD ratio)). In the original study [7] these re-
sults were categorized as positive or negative using a
ﬁxed cut-oﬀ [4] (Table 1). Rubella virus-speciﬁc IgG
results from paired serum samples using a commercial
ELISA (Behring Enzygnost, Dade-Behring, Milton
Keynes, UK), classiﬁed using the ﬁxed cut-oﬀ rec-
ommended by the manufacturer, were also available
(Table 1).
The age-stratiﬁed distributionof results for oral ﬂuid
samples was considered in comparison to those from
the paired sera. The distribution of reactivity observed
in samples forwhich the paired serumwas negativewas
shown to be independent of age and approximated a
Normal distribution (Fig. 1a). In samples for which
the paired serum was positive the mean reactivity de-
creased with age (Fig. 1b). This information was used
to motivate our choice of mixture model below.
Model
In constructing a mixture model, it is assumed that
samples in the survey were taken from individuals with
one of several diﬀerent immune statuses. The simplest
model has just two statuses, uninfected and previously
infected. It is assumed that for each status the anti-
body results can be described by some distribution. If
the parameters of these distributions (e.g. mean and
standard deviation for a Normal distribution) and the
proportion of samples with each status were known,
the overall distribution of antibody results could be
determined. Mixture modelling takes the inverse ap-
proach and estimates the distribution parameters for
each status and the proportion of samples with each
status by ﬁtting the overall distribution of results.
For the present analysis, a mixture model was con-
structed to estimate the prevalence of rubella virus
antibody using data from the oral ﬂuid samples on the
assumption that each individual had one of three
statuses : negative, weak positive and strong positive.
The proportion of samples with each status was as-
sumed to be age-dependent. For a given status, the
Table 1. Age-speciﬁc prevalence of rubella virus anti-
body in paired serum and saliva samples using a ﬁxed
cut-oﬀ
Age
group
Number of
samples
Number (%)
positive
in serum
Number (%)
positive
in saliva
1–4 90 27 (30) 30 (33)
5–9 155 101 (65) 99 (64)
10–14 141 108 (77) 94 (67)
15–24 135 123 (91) 109 (81)
25–44 164 163 (99) 112 (68)
45+ 152 144 (95) 99 (65)
All ages 837 666 (80) 543 (65)
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distribution of results in the oral ﬂuid assay was as-
sumed to be independent of age, and to follow a
Normal distribution. Age-related changes in reactivity
of samples from infected persons are reﬂected in the
model by changes in the relative proportions weak and
strong positive. In all 18 parameters (12 describing the
proportions in each component for each age group
and 6 describing the mean and standard deviation of
the 3 component distributions) were estimated from
120 data points (the distribution of results in the 6
age groups). Details of the parameter estimation
procedure are given in the appendix.
RESULTS
The proportions of samples attributed by the mix-
ture model to the negative, strong positive and weak
positive components are shown in Figure 2. The
prevalence of previous infection is calculated as
the sum of the strong and weak positive components.
The estimated distribution of results within each com-
ponent is shown in Figure 3.
The model provided a good ﬁt to the data, which
is shown in Figure 4 and reﬂected by the deviance
(D=97.75 on 102 D.F.). Clearly deﬁned positive and
negative distributions can be seen for young children,
but these become progressively obscured at older ages.
The proportion uninfected estimated by the model
(Table 2) is compared to the proportion negative for
rubella virus antibody in the original study using
both oral ﬂuids and matching sera (Fig. 5). The model
estimates are very similar to the serum results, and
overcome the lack of sensitivity associated with use of
a ﬁxed cut-oﬀ in the oral ﬂuid assay.
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Fig. 1.Distribution of reactivity in the oral ﬂuid assay by age group: (a) samples forwhich the paired serum samplewas negative
for rubella antibody; (b) samples for which the paired serum sample was positive for rubella antibody.
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Amodel using a single Normal component tomodel
the infected population provided a signiﬁcantly worse
ﬁt than the model with two (weak and strong) positive
components (D=212.80 on 110 D.F., P<0.00001).
Allowing the parameters of this distribution (mean and
standard deviation) to take diﬀerent values in each age
group improved the ﬁt (D=115.82 on 100 D.F.), but it
was still considerably worse than the ﬁt for the model
with weak and strong positive components. Modelling
the uninfected population with a Gamma distribution
rather than a Normal distribution had little eﬀect on
the ﬁt of the model or the estimated prevalence.
DISCUSSION
This study conﬁrms the potential of age-speciﬁc mix-
ture models as a tool for the analysis of population-
based seroprevalence studies, in particular those that
utilize oral ﬂuids rather than serum. In such studies
individual test results are only of importance for their
contribution to the overall prevalence. Therefore it is
not necessary to use a cut-oﬀ to categorize individual
samples as positive or negative, but rather use an age-
speciﬁc mixture model to analyse the distribution of
the quantitative results to provide a direct estimate
of the age speciﬁc prevalence [8]. The prevalence
estimates from the age-speciﬁc model with three
component distributions applied to oral ﬂuid data
were in close agreement with results from matching
sera using a commercial assay, which may be con-
sidered to represent the true prevalence of rubella virus
antibody in the population studied.
The principal decisions in conducting a mixture
model analysis involve the number of components to
use and the choice of distribution for each component.
In this analysis, we were able to base our choices on the
distribution of reactivity observed in oral ﬂuid samples
for which the result on the paired serum was known.
As a compromise between simplicity and ﬂexibility, we
did not attempt to model the mechanism of decaying
antibody levels, only to describe the distribution result-
ing from this process. We thus modelled the infected
population as a mixture of strong positive and weak
positive Normal components. The importance of in-
cluding the ‘weak positive’ component is demon-
strated by the greatly improved ﬁt over a model with
just positive and negative components. The increase
with age in the proportion of positives in the ‘weak
positive’ component, particularly noticeable after age
15 years, reﬂects the decay of rubella speciﬁc antibody
levels in persons infected many years previously as
observed in other studies [4–7]. The approach of using
strong and weak positive components to introduce
ﬂexibility into the infected distribution worked well
in this study because the distribution of results for
the uninfected population did not change with age
(Fig. 1a). In a situation where the distribution of re-
sults from the uninfected population was also age-
dependent (especially if the mean increased with age,
perhaps due to acquisition of cross-reacting anti-
bodies) it may be necessary to model the mechanisms
producing these eﬀects, rather than employing such
an heuristic device.
The availability of serum results in this study di-
rected the construction of the mixture model by en-
abling us to conﬁrm the validity of our assumptions
regarding the distribution of reactivity in infected and
uninfected individuals. The serum results, however,
were not used in the parameter estimation process.
Future studies using the same oral ﬂuid assay in un-
vaccinated populations may be conducted using oral
ﬂuid samples only, without the need for paired serum
samples.
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Fig. 2. Estimated proportion of samples negative %, weak
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Fig. 3. Estimated distribution of reactivity in the oral ﬂuid
assay for negative,weakpositive and strongpositive samples.
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A variety of IgG assays designed speciﬁcally for use
with oral ﬂuids are available for a range of other acute
self-limiting virus infections [9–14]. Due to decaying
IgG over time since exposure, it is likely that these will
also experience diﬃculty in distinguishing weak posi-
tive and negative results due to a combination of the
low concentration of immunoglobulins found in oral
ﬂuids and limitations in current immunoassay detec-
tion systems. When using a ﬁxed cut-oﬀ value, data
fromprevalence studies utilizing oral ﬂuids are likely to
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Fig. 4. Distribution of reactivity in the oral ﬂuid assay by age group: observed data (bars) and model ﬁt (line).
Table 2. Maximum likelihood estimates (95% CI) of
the age-speciﬁc proportion of negative samples
Age
group
Proportion
negative (%)
1–4 73 (54–83)
5–9 37 (27–47)
10–14 27 (17–39)
15–24 2 (0–11)
25–44 0 (0–10)
45+ 5 (0–18)
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Fig. 5. Proportion of samples negative for rubella antibody
by age : comparison of results from serum samples, oral ﬂuid
samples with ﬁxed cut-oﬀ, and oral ﬂuid samples using
mixture model.
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be compromised and not accurately reﬂect those using
sera, particularly in older age groups. However, this
study has demonstrated that an accurate estimate of
age-speciﬁc antibody prevalence can be achieved if
mixture models are applied to results from population
immunity studies using oral ﬂuids. This therefore
brings a step nearer the realization of using oral ﬂuids
to replace serum for prevalence studies, enabling the
compliance advantages of oral ﬂuids to be fully
exploited for this purpose.
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APPENDIX – DESCRIPTION OF THE
MIXTURE MODEL
The reactivity x in the oral ﬂuid assay was deﬁned as
the logarithm of the OD ratio. Individual results are
aggregated into 120 data points comprising 6 age
groups (1–4, 5–9, 10–14, 15–24, 25–44 and 45 years
or more) by 20 reactivity categories : njk denotes
the number of results from person in age group j
( j=1, …, 6) falling in the kth reactivity category
(xkx1<xfxk : x0=x1, x20=1, xk=x0.5+0.1k
for k=1, …, 19).
Mixture model
Let fx(x), f w(x), f s(x) denote the distributions for
the negative, weak positive and strong positive
components respectively. Let pxj , p
w
j , p
s
j denote the
proportionof samples from the negative,weak positive
and strong positive components respectively in age
group j ( pxj +p
w
j +p
s
j=1). Then the overall density of
results at age j, fj, is a mixture of the three component
densities,
fj(x)=pxj f
x(x)+pwj f
w(x)+psj f
s(x):
Parameter estimation
LetNjdenote the number of individuals of age j, so that
Nj=Sknjk. Then (nj,1, …, nj,20) is multinomial with in-
dex Nj and probabilities pjk, where
pjk=
Z xk
xkx1
fj(x) dx:
Maximum likelihood estimates for the parameters
were obtained by minimizing the deviance D
D=2
X6
j=1
X20
k=1
njk log
njk
pjk Nk
 
:
Likelihood-based 95% conﬁdence intervals for the
age speciﬁc prevalence were obtained by ﬁnding the
maximum andminimum values for which the deviance
was within 3.84 of the minimum (Table 2).
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